Cross-talk between adenosine and opioid receptors

Drug News and Perspectives

Volumn 18, Issue 4, 2005, Pages 237-242

  Peart, Jason N ^a   Gross, Garrett J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 5 IODOTUBERCIDIN; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ADENYLATE CYCLASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; FENTANYL; G PROTEIN COUPLED RECEPTOR; INTERLEUKIN 2; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; OPIATE; OPIATE RECEPTOR; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; ROTTLERIN; SOMATOSTATIN;

ADRENERGIC SYSTEM; CENTRAL NERVOUS SYSTEM; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; RECEPTOR SENSITIVITY; REPERFUSION INJURY; REVIEW;

ANIMALS; BRAIN; HUMANS; MYOCARDIAL REPERFUSION INJURY; RECEPTORS, OPIOID; RECEPTORS, PURINERGIC P1;

EID: 23244438166     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2005.18.4.908657     Document Type: Review

References (56)

1. Peart, J.N. and Gross, G.J. Adenosine and opioid receptor-mediated cardioprotection in the rat: Evidence for cross-talk between receptors. Am J Physiol Heart Circ Physiol 2003, 285: H81-9.
2. Coupar, LM. and Tran, B.L. Withdrawal and bidirectional cross-withdrawal responses in rats treated with adenosine agonists and morphine. Life Sci 2001, 69: 779-90.
3. Shryock, J.C. and Belardinelli, L. Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology, and pharmacology. Am J Cardiol 1997, 79: 2-10.
4. Headrick, J.P., Hack, B. and Ashton, K.J. Acute adenosinergic cardioprotection in ischemic-reperfused hearts. Am J Physiol Heart Circ Physiol 2003, 285: H1797-818.
5. Sawynok, J. and Liu, X.J. Adenosine in the spinal cord and periphery: Release and regulation of pain. Prog Neurobiol 2003, 69: 313-40.
6. Sweeney, M.I. Neuroprotective effects of adenosine in cerebral ischemia: Window of opportunity. Neurosci Biobehav Rev 1997, 21: 207-17.
7. Peart, J., Willems, L. and Headrick, J.P. Receptor and non-receptor-dependent mechanisms of cardioprotection with adenosine. Am J Physiol Heart Circ Physiol 2003, 284: H519-27.
8. Headrick, J.P. Ischemic preconditioning: Bioenergetic and metabolic changes and the role of endogenous adenosine. J Mol Cell Cardiol 1996, 28: 1227-40.
9. Pugsley, M.K. The opioid receptor independent actions of kappa receptor agonists in the cardiovascular system. Curr Pharm Des 2004, 10: 2429-44.
10. Smith, A.P. and Lee, N.M. Opioid receptor interactions: Local and nonlocal, symmetric and asymmetric, physical and functional. Life Sci 2003, 73: 1873-93.
11. Varga, E.V., Rubenzik, M.K., Stropova, D. et al. Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic delta-opioid agonist treatment. J Pharmacol Exp Ther 2003, 306: 109-15.
12. Gross, G.J. Role of opioids in acute and delayed preconditioning. J Mol Cell Cardiol 2003, 35: 709-18.
13. Bolling, S.F., Tramontini, N.L., Kilgore, K.S., Su, T.P., Oeltgen, P.R. and Harlow, H.H. Use of "natural" hibernation induction triggers for myocardial protection. Ann Thorac Surg 1997, 64: 623-7.
14. Wang, T.L., Chang, H., Hung, C.R. and Tseng, Y.Z. Morphine preconditioning attenuates neutrophil activation in rat models of myocardial infarction. Cardiovasc Res 1998, 40: 557-63.
15. Zhang, Y., Irwin, M.G. and Wong, T.M. Remifentanil preconditioning protects against ischemic injury in the intact rat heart. Anesthesiology 2004, 101: 918-23.
16. Gross, G.J. and Peart, J.N. KATP channels and myocardial preconditioning: An update. Am J Physiol Heart Circ Physiol 2003, 285: H921-30.
17. Peart, J.N. and Gross, G.J. Adenosine kinase inhibition mediates cardioprotection via A1 adenosine receptors and mitochondrial KATP channels. FASEB J 2003, 17: A230.
18. Peart, J.N. and Gross, G.J. Cross-talk between adenosine and opioid receptors eliciting cardioprotection requires an intact CNS. FASEB J 2004, 18: A264.
19. Kato, R., Ross, S. and Foex, P. Fentanylprotects the heart against ischaemic injury via opioid receptors, adenosine A1 receptors and KATP channel linked mechanisms in rats. Br J Anaesth 2000, 84: 204-14.
20. Pepe, S., van den Brink, O.W., Lakatta, E.G. and Xiao, R.P. Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart. Cardiovasc Res 2004, 63: 414-22.
21. Pepe, S., Xiao, R.P., Hohl, C., Altschuld, R. and Lakatta, E.G. 'Cross talk' between opioid peptide and adrenergic receptor signaling in isolated rat heart. Circulation 1997, 95: 2122-9.
22. Xiao, R.P., Pepe, S., Spurgeon, H.A., Capogrossi, M.C. and Lakatta, E.G. Opioid peptide receptor stimulation reverses beta-adrenergic effects in rat heart cells. Am J Physiol 1997, 272: H797-805.
23. Cao, C.M., Xia, Q., Chen, Y.Y., Zhang, X. and Shen, Y.L. Opioid receptor-mediated effects of interleukin-2 on the [Ca2+]i transient and contraction in isolated ventricular myocytes of the rat. Pflugers Arch 2002, 443: 635-12.
24. Cao, C.M., Xia, Q., Tu, J., Chen, M., Wu, S. and Wong, T.M. Cardioprotection of interleukin-2 is mediated via kappa-opioid receptors. J Pharmacol Exp Ther 2004, 309: 560-7.
25. Sulakhe, P.V., Vo, X.T. and Mainra, R.R. Differential nature of cross-talk among three G-coupled receptors regulating adenylyl cyclase in rat cardiomyocytes chronically exposed to receptor agonists. Mol Cell Biochem 1997, 176: 75-82.
26. Minatoguchi, S., Uno, Y., Kariya, T. et al. Cross-talk among noradrenaline, adenosine and protein kinase C in the mechanisms of ischemic preconditioning in rabbits. J Cardiovasc Pharmacol 2003, 41: 839-47.
27. Ho, I.K., Loh, H.H. and Way, E.L. Cyclic adenosine monophosphate antagonism of morphine analgesia. J Pharmacol Exp Ther 1973, 185: 336-46.
28. Keil, G.J. II and DeLander, G.E. Adenosine kinase and adenosine deaminase inhibition modulate spinal adenosine- and opioid agonist-induced antinociception in mice. Eur J Pharmacol 1994, 271: 37-46.
29. Sawynok, J., Espey, M.J. and Reid, A. 8-Phenyltheophylline reverses the antinociceptive action of morphine in the periaque-ductal gray. Neuropharmacology 1991, 30: 871-7.
30. Kaplan, G.B., Leite-Morris, K.A. and Sears, M.T. Alterations of adenosine A1 receptors in morphine dependence. Brain Res 1994, 657: 347-50.
31. Kaplan, G.B. and Leite-Morris, K.A. Upregulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice. Brain Res 1997, 763: 215-20.
32. Sawynok, J. Adenosine receptor activation and nociception. Eur J Pharmacol 1998, 347: 1-11.
33. Sandner-Kiesling, A., Li, X. and Eisenach, J.C. Morphine-induced spinal release of adenosine is reduced in neuropathic rats. Anesthesiology 2001, 95: 1455-9.
34. Halimi, G., Devaux, C., Clot-Faybesse, O. et al. Modulation of adenosine concentration by opioid receptor agonists in rat striatum. Eur J Pharmacol 2000, 398: 217-24.
35. Cahill, C.M., White, T.D. and Sawynok, J. Spinal opioid receptors and adenosine release: Neurochemical and behavioral characterization of opioid subtypes. J Pharmacol Exp Ther 1995, 275: 84-93.
36. Sweeney, M.I., White, T.D. and Sawynok, J. Morphine-evoked release of adenosine from the spinal cord occurs via a nucleoside carrier with differential sensitivity to dipyridamole and nitrobenzylthioinosine. Brain Res 1993, 614: 301-7.
37. DeLander, G.E. and Keil, G.J. II. Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice. J Pharmacol Exp Ther 1994, 268: 943-51.
38. Eisenach, J.C., Hood, D.D., Curry, R., Sawynok, J., Yaksh, T.L. and Li, X. Intrathecal but not intravenous opioids release adenosine from the spinal cord. J Pain 2004, 5: 64-8.
39. Brundege, J.M. and Williams, J.T. Increase in adenosine sensitivity in the nucleus accumbens following chronic morphine treatment. J Neurophysiol 2002, 87: 1369-75.
40. Bailey, A., Weber, D., Zimmer, A., Zimmer, A.M., Hourani, S.M. and Kitchen, I. Quantitative autoradiography of adenosine receptors and NBTI-sensitive adenosine transporters in the brains of mice deficient in the preproenkephalin gene. Brain Res 2004, 1025: 1-9.
41. Berrendero, F., Castane, A., Ledent, C., Parmentier, M., Maldonado, R. and Valverde, O. Increase of morphine withdrawal in mice lacking A2a receptors and no changes in CB1/A2a double knockout mice. Eur J Neurosci 2003, 17: 315-24.
42. Bailey, A., Davis, L., Lesscher, H.M. et al. Enhanced morphine withdrawal and micro-opioid receptor G-protein coupling in A2A adenosine receptor knockout mice. J Neurochem 2004, 88: 827-34.
43. Bailey, A., Ledent, C., Kelly, M., Hourani, S.M. and Kitchen, I. Changes in spinal delta and kappa opioid systems in mice deficient in the A2A receptor gene. J Neurosci 2002, 22: 9210-20.
44. Stella, L., De Novellis, V., Vitelli, M.R. et al. Interactive role of adenosine and dopamine in the opiate withdrawal syndrome. Naunyn Schmiedebergs Arch Pharmacol 2003, 368: 113-8.
45. White, P.J., Rose'Meyer, R.B. and Hope, W. Changes in adenosine receptors mediating hypotension in morphine-dependent rats. Eur J Pharmacol 1995, 294: 215-20.
46. White, P.J., Hope, W. and Rose'Meyer, R.B. The role of adenosine in the hypotensive actions of morphine. Eur J Pharmacol 1995, 286: 315-9.
47. George, S.R., Fan, T., Xie, Z. et al. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 2000, 275: 26128-35.
48. Gomes, I., Jordan, B.A., Gupta, A., Trapaidze, N., Nagy, V. and Devi, L.A Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. J Neurosci 2000, 20: RC110.
49. Jordan, B.A. and Devi, L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999, 399: 697-700.
50. Pfeiffer, M., Koch, T., Schroder, H., Laugsch, M., Hollt, V. and Schulz, S. Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization. J Biol Chem 2002, 277: 19762-72.
51. Xu, H., Partilla, J.S., de Costa, B.R., Rice, K.C. and Rothman, R.B. Differential binding of opioidpeptides and other drugs to two subtypes of opioid delta ncx binding sites in mouse brain: Further evidence for delta receptor heterogeneity. Peptides 1993, 14: 893-907.
52. Jordan, B.A., Trapaidze, N., Gomes, I., Nivarthi, R. and Devi, L.A. Oligomerization of opioid receptors with beta 2-adrenergic receptors: A role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci USA 2001, 98: 343-8.
53. Yoshioka, K., Hosoda, R., Kuroda, Y. and Nakata, H. Hetero- oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains. FEBS Lett 2002, 531: 299-303.
54. Gines, S., Hillion, J., Torvinen, M. et al. Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci USA 2000, 97: 8606-11.
55. Kamiya, T., Saitoh, O., Yoshioka, K. and Nakata, H. Oligomerization of adenosine A2A and dopamine D2 receptors in living cells. Biochem Biophys Res Commun 2003, 306: 544-9.
56. Yao, L., Fan, P., Jiang, Z., Mailliard, W.S., Gordon, A.S. and Diamond, I. Addicting drugs utilize a synergistic molecular mechanism in common requiring adenosine and Gi-beta gamma dimers. Proc Natl Acad Sci USA 2003, 100: 14379-84.